Literature DB >> 25382874

Inorganic chemistry in nuclear imaging and radiotherapy: current and future directions.

Valerie Carroll1, Dustin W Demoin1, Timothy J Hoffman2, Silvia S Jurisson1.   

Abstract

Radiometals play an important role in diagnostic and therapeutic radiopharmaceuticals. This field of radiochemistry is multidisciplinary, involving radiometal production, separation of the radiometal from its target, chelate design for complexing the radiometal in a biologically stable environment, specific targeting of the radiometal to its in vivo site, and nuclear imaging and/or radiotherapy applications of the resultant radiopharmaceutical. The critical importance of inorganic chemistry in the design and application of radiometal-containing imaging and therapy agents is described from a historical perspective to future directions.

Entities:  

Keywords:  Bifunctional chelates; Nuclear imaging; Radiometals; Radiotherapy; Specific targeting

Year:  2012        PMID: 25382874      PMCID: PMC4221859          DOI: 10.1524/ract.2012.1964

Source DB:  PubMed          Journal:  Radiochim Acta        ISSN: 0033-8230            Impact factor:   1.440


  131 in total

1.  99mTc-Labeled Small Peptides as Diagnostic Radiopharmaceuticals.

Authors:  S Liu; D S Edwards
Journal:  Chem Rev       Date:  1999-09-08       Impact factor: 60.622

Review 2.  Positron-emitting isotopes produced on biomedical cyclotrons.

Authors:  Paul McQuade; Douglas J Rowland; Jason S Lewis; Michael J Welch
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

3.  Metallic radionuclides in the development of diagnostic and therapeutic radiopharmaceuticals.

Authors:  Sibaprasad Bhattacharyya; Manish Dixit
Journal:  Dalton Trans       Date:  2011-05-03       Impact factor: 4.390

4.  Efficient bifunctional gallium-68 chelators for positron emission tomography: tris(hydroxypyridinone) ligands.

Authors:  David J Berry; Yongmin Ma; James R Ballinger; Richard Tavaré; Alexander Koers; Kavitha Sunassee; Tao Zhou; Saima Nawaz; Gregory E D Mullen; Robert C Hider; Philip J Blower
Journal:  Chem Commun (Camb)       Date:  2011-05-27       Impact factor: 6.222

5.  Biodistribution of model 105Rh-labeled tetradentate thiamacrocycles in rats.

Authors:  N Li; M Struttman; C Higginbotham; A J Grall; J F Skerlj; J F Vollano; S A Bridger; L A Ochrymowycz; A R Ketring; M J Abrams; W A Volkert
Journal:  Nucl Med Biol       Date:  1997-01       Impact factor: 2.408

Review 6.  New directions in the coordination chemistry of 99mTc: a reflection on technetium core structures and a strategy for new chelate design.

Authors:  Sangeeta Ray Banerjee; Kevin P Maresca; Lynn Francesconi; John Valliant; John W Babich; Jon Zubieta
Journal:  Nucl Med Biol       Date:  2005-01       Impact factor: 2.408

7.  89Zr-DFO-J591 for immunoPET of prostate-specific membrane antigen expression in vivo.

Authors:  Jason P Holland; Vadim Divilov; Neil H Bander; Peter M Smith-Jones; Steven M Larson; Jason S Lewis
Journal:  J Nucl Med       Date:  2010-07-21       Impact factor: 10.057

Review 8.  Peptide-based radiopharmaceuticals and cytotoxic conjugates: potential tools against cancer.

Authors:  S M Okarvi
Journal:  Cancer Treat Rev       Date:  2007-09-17       Impact factor: 12.111

9.  Subcellular distribution and metabolism studies of the potential myocardial imaging agent [99mTc(N)(DBODC)(PNP5)]+.

Authors:  Cristina Bolzati; Mario Cavazza-Ceccato; Stefania Agostini; Shinji Tokunaga; Dario Casara; Giuliano Bandoli
Journal:  J Nucl Med       Date:  2008-07-16       Impact factor: 10.057

10.  MO tripeptide diastereomers (M=99/99mTc, Re): models to identify the structure of 99mTc peptide targeted radiopharmaceuticals.

Authors:  Melchor V Cantorias; Robertha C Howell; Louis Todaro; John E Cyr; Dietmar Berndorff; Robin D Rogers; Lynn C Francesconi
Journal:  Inorg Chem       Date:  2007-08-11       Impact factor: 5.165

View more
  8 in total

1.  Coordination chemistry of [Y(pypa)]- and comparison immuno-PET imaging of [44Sc]Sc- and [86Y]Y-pypa-phenyl-TRC105.

Authors:  Lily Li; María de Guadalupe Jaraquemada-Peláez; Eduardo Aluicio-Sarduy; Xiaozhu Wang; Todd E Barnhart; Weibo Cai; Valery Radchenko; Paul Schaffer; Jonathan W Engle; Chris Orvig
Journal:  Dalton Trans       Date:  2020-04-09       Impact factor: 4.390

2.  Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals.

Authors:  Brian M Zeglis; Jacob L Houghton; Michael J Evans; Nerissa Viola-Villegas; Jason S Lewis
Journal:  Inorg Chem       Date:  2013-12-06       Impact factor: 5.165

3.  Novel rhenium(III, IV, and V) tetradentate N2O2 Schiff base mononuclear and dinuclear complexes.

Authors:  David A Rotsch; Kimberly M Reinig; Eric M Weis; Anna B Taylor; Charles L Barnes; Silvia S Jurisson
Journal:  Dalton Trans       Date:  2013-07-04       Impact factor: 4.390

Review 4.  Bifunctional chelators for radiorhenium: past, present and future outlook.

Authors:  Diana R Melis; Andrew R Burgoyne; Maarten Ooms; Gilles Gasser
Journal:  RSC Med Chem       Date:  2022-01-14

5.  Monooxorhenium(V) complexes with 222-N2S2 MAMA ligands for bifunctional chelator agents: Syntheses and preliminary in vivo evaluation.

Authors:  Dustin Wayne Demoin; Ashley N Dame; William D Minard; Fabio Gallazzi; Gary L Seickman; Tammy L Rold; Nicole Bernskoetter; Michael E Fassbender; Timothy J Hoffman; Carol A Deakyne; Silvia S Jurisson
Journal:  Nucl Med Biol       Date:  2016-08-31       Impact factor: 2.408

Review 6.  Perspectives on metals-based radioimmunotherapy (RIT): moving forward.

Authors:  Jordan M White; Freddy E Escorcia; Nerissa T Viola
Journal:  Theranostics       Date:  2021-04-15       Impact factor: 11.556

7.  PET Imaging of Extracellular pH in Tumors with (64)Cu- and (18)F-Labeled pHLIP Peptides: A Structure-Activity Optimization Study.

Authors:  Dustin Wayne Demoin; Linden C Wyatt; Kimberly J Edwards; Dalya Abdel-Atti; Mirkka Sarparanta; Jacob Pourat; Valerie A Longo; Sean D Carlin; Donald M Engelman; Oleg A Andreev; Yana K Reshetnyak; Nerissa Viola-Villegas; Jason S Lewis
Journal:  Bioconjug Chem       Date:  2016-07-21       Impact factor: 4.774

Review 8.  Methods to Enhance the Metabolic Stability of Peptide-Based PET Radiopharmaceuticals.

Authors:  Brendan J Evans; Andrew T King; Andrew Katsifis; Lidia Matesic; Joanne F Jamie
Journal:  Molecules       Date:  2020-05-14       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.